Air Liquide Healthcare launches the Tandem Diabetes Care t:slim X2™ insulin pump in Ireland

Air Liquide Healthcare has formally announced the launch of the Tandem t:slim X2™ insulin pump, in Ireland. The t:slim X2 is up to 38% smaller than other CGM-enabled insulin pumps and has a watertight (IPX7) aluminium case and a colour touchscreen interface. It features continuous glucose monitoring (CGM) integration, a rechargeable battery and USB connectivity.


The pump is capable of remote feature upgrades, much like a smartphone, which can be carried out throughout the four-year warranty of the pump. Pump users can also upload their pump data using the Diasend or Tidepool diabetes data management systems, allowing their clinical teams to then review patterns in data and help make changes in pump settings when necessary.


When integrated with the Dexcom G6 CGM system, users have the option of two predictive insulin delivery technologies;

Basal-IQ™ Technology is a predictive low glucose suspend feature that links with Dexcom G6 CGM to help the management of hypoglycaemia with zero fingersticks. Basal-IQ helps to reduce the frequency and duration of low-glucose events by predicting glucose levels 30 minutes ahead and suspending insulin if they are expected to drop below 4.4 mmol/L, or if an actual CGM reading falls below 3.9 mmol/L, meaning users can spend less time worrying about lows and more time living their life.


Control-IQ™ Technology is an advanced hybrid closed-loop system that uses Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and adjusts insulin delivery accordingly, including the delivery of automatic correction boluses. If sensor glucose values are predicted to drop below 6.3mmol/L, basal insulin delivery is reduced, and when predicted to be below 3.9mmol/L, basal insulin delivery is stopped.


If sensor glucose values are predicted to be above 8.9mmol/L, basal insulin will be increased. If sensor glucose values are predicted to be above 10mmol/L, Control-IQ Technology calculates an automatic correction bolus. Automatic correction boluses are delivered up to once per hour as

needed. Control-IQ Technology has been clinically proven to increase a user’s time in range by, on average, 2.6 hours per day.


Air Liquide Healthcare supply insulin pumps to Diabetes clinics directly and the consumables (infusion sets and insulin cartridges for the pump) are reimbursed through the HSE PCRS scheme, similar to many other available technologies.


More information on Tandem t:slim X2 insulin pump can be found at

If you are interested in a Tandem t:slim X2 insulin pump, as a first step speak to your diabetes team.